The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

A large recall of shredded cheese sold under several brands is underway after the manufacturer reported the product may ...

The U.S. Food and Drug Administration has approved an expanded indication for Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults with relapsed ...

The FDA has approved pirtobrutinib for certain adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.The new indication applies to adults who previously have ...

Jaypirca was approved for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were previously treated with a covalent Bruton ...

Pirtobrutinib is now FDA-approved for relapsed/refractory CLL/SLL after prior covalent BTK inhibitor therapy, following its 2023 accelerated approval. The BRUIN-CLL-321 trial showed pirtobrutinib ...

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval to ...

A new study shows that some widely used BPA replacements can kill cells and disrupt key functions, prompting scientists to ...

SAN FRANCISCO, CA / ACCESS Newswire / / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the U.S. Food and Drug ...

On November 19, 2025, the Food and Drug Administration granted accelerated approval to Bayer’s (BAYRY) sevabertinib, a kinase inhibitor, for adults with locally advanced or metastatic, non-squamous ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...